Gene · 1105
Papers1,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,932
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Five years of experience in the Epigenetics and Chromatin Clinic: what have we learned and where do we go from here? | Hum Genet | 2024 | 36952035 | PubTator, text mining | PubMed |
| Exploiting the DNA Damage Response for Prostate Cancer Therapy. | Cancers (Basel) | 2023 | 38201511 | PubTator, text mining | PubMed |
| Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer. | Cancers (Basel) | 2023 | 38201475 | PubTator, text mining | PubMed |
| A Saudi Girl With Co-occurring CHD1 (Pilarowski-Bjornsson Syndrome) and ASH1L Gene Variants. | Cureus | 2023 | 38174187 | PubTator, text mining | PubMed |
| PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma. | Invest Ophthalmol Vis Sci | 2023 | 38149971 | PubTator, text mining | PubMed |
| Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives. | J Clin Med | 2023 | 38137784 | PubTator, text mining | PubMed |
| Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers. | Biomolecules | 2023 | 38136573 | PubTator, text mining | PubMed |
| Symphony in the crowd: Key genetic alterations in prostate cancer. | Cancer Innov | 2023 | 38089408 | PubTator, text mining | PubMed |
| Simultaneous CRISPR screening and spatial transcriptomics reveals intracellular, intercellular, and functional transcriptional circuits. | bioRxiv | 2023 | 38076932 | PubTator, text mining | PubMed |
| Proton Therapy in the Treatment of Men with Breast Cancer. | Int J Part Ther | 2023 | 38075485 | PubTator, text mining | PubMed |
| Mechanistic Insights on Localized to Metastatic Prostate Cancer Transition and Therapeutic Opportunities. | Res Rep Urol | 2023 | 38050587 | PubTator, text mining | PubMed |
| Long-term female bias in sex ratios across life stages of Harpy Eagle, a large raptor exhibiting reverse sexual size dimorphism. | R Soc Open Sci | 2023 | 38026037 | PubTator, text mining | PubMed |
| Comparison of survival between diffuse type and intestinal type early-onset gastric cancer patients: A large population-based study. | Medicine (Baltimore) | 2023 | 38013337 | PubTator, text mining | PubMed |
| ΔNp63α facilitates proliferation and migration, and modulates the chromatin landscape in intrahepatic cholangiocarcinoma cells. | Cell Death Dis | 2023 | 38012140 | PubTator, text mining | PubMed |
| NGS Custom Panel Implementation in Patients with Non-Syndromic Autism Spectrum Disorders in the Clinical Routine of a Tertiary Hospital. | Genes (Basel) | 2023 | 38003033 | PubTator, text mining | PubMed |
| Public Awareness and Acceptability of PGT-M in Cancer Predisposition Syndromes. | Genes (Basel) | 2023 | 38003012 | PubTator, text mining | PubMed |
| Predicting Prognosis and Immunotherapy Response in Multiple Cancers Based on the Association of PANoptosis-Related Genes with Tumor Heterogeneity. | Genes (Basel) | 2023 | 38002938 | PubTator, text mining | PubMed |
| Multiomics of HER2-low triple-negative breast cancer identifies a receptor tyrosine kinase-relevant subgroup with therapeutic prospects. | JCI Insight | 2023 | 37991016 | PubTator, text mining | PubMed |
| Neuronal transcription of autism gene PTCHD1 is regulated by a conserved downstream enhancer sequence. | Sci Rep | 2023 | 37990104 | PubTator, text mining | PubMed |
| Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival. | Cell Commun Signal | 2023 | 37974198 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1105/papers?page=6